A pharmaceutical company targeting unmet clinical needs.

Herantis Pharma was created by a merger of two pharmaceutical companies, Hermo Pharma and Laurantis Pharma.

Pipeline

Overview

Herantis has a product development portfolio focused in areas of unmet clinical need, based on internationally recognized science.

Read More

Notice to convene Herantis Pharma Plc's Extraordinary General Meeting of shareholders

Notice to convene Herantis Pharma Plc's Extraordinary General Meeting of shareholders Herantis Pharma Plc Company release 15 February 2019 at…

Read More

Herantis Pharma Plc is planning a directed share issue and prepares for a contemplated secondary listing on the First North Stockholm marketplace

Herantis Pharma Plc is planning a directed share issue to a limited number of investors and the company's directors and…

Read More

Herantis Pharma Oyj: Manager's Transactions - Pekka Simula

Herantis Pharma Oyj: Manager's Transactions - Pekka Simula Herantis Pharma Plc Company release 21 December 2018 at 9:00 am Herantis…

Read More

Investors

Herantis shares are listed on NASDAQ OMX Helsinki First North Finland. Read More

New therapies for a better life.